摘要: Percutaneous coronary interventions (PCI) mandate usage of anticoagulants to facilitate a successful and safe procedure. This chapter reviews commonly used anticoagulant regimens for PCI with tailored guidance the acute setting, in particular primary ST-elevation myocardial infarction (STEMI).
springer.com
sci-hub.st 参考文章(20)
Jonathan D. Marmur, Manish Lakhani, Erdal Cavusoglu, The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration. Journal of Invasive Cardiology. ,vol. 17, pp. 416- 421 ,(2005)
Jonathan D Marmur, Shyam Poludasu, Erdal Cavusoglu, Renee P Bullock-Palmer, Avoiding Intelligence Failures in the Cardiac Catheterization Laboratory: Strategies for the Safe and Rational Use of Dalteparin or Enoxaparin during Percutaneous Coronary Intervention Journal of Invasive Cardiology. ,vol. 21, pp. 653- 664 ,(2009)
Salim Yusuf, Shamir R Mehta, Susan Chrolavicius, Janine Pogue, Christopher B Granger, Andrzej Budaj, Ron JG Peters, Jean-Pierre Bassand, Lars Wallentin, Campbell Joyner, Keith AA Fox, None, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA. ,vol. 295, pp. 1519- 1530 ,(2006) , 10.1001/JAMA.295.13.JOC60038
Steen Husted, Lars Wallentin, Felicita Andreotti, Harald Arnesen, Fedor Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Kristensen, Gregory Y. H. Lip, João Morais, Lars Rasmussen, Agneta Siegbahn, Freek W. A. Verheugt, Jeffrey I. Weitz, Raffaele De Caterina, Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thrombosis and Haemostasis. ,vol. 109, pp. 769- 786 ,(2013) , 10.1160/TH12-06-0403
Irbaz Bin Riaz, Majid Asawaeer, Haris Riaz, Wendy M. Gabriel, Ismail K. Tabash, Jawad Bilal, Joseph S. Alpert, Optimal anticoagulation duration of unfractionated and low molecular weight heparin in non-ST elevation acute coronary syndrome: A systematic review of the literature International Journal of Cardiology. ,vol. 177, pp. 461- 466 ,(2014) , 10.1016/J.IJCARD.2014.09.105
Yaling Han, Jincheng Guo, Yang Zheng, Hongyun Zang, Xi Su, Yu Wang, Shaoliang Chen, Tiemin Jiang, Ping Yang, Jiyan Chen, Dongju Jiang, Quanmin Jing, Zhenyang Liang, Haiwei Liu, Xin Zhao, Jing Li, Yi Li, Bo Xu, Gregg W Stone, Bright Investigators, None, Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The BRIGHT Randomized Clinical Trial JAMA. ,vol. 313, pp. 1336- 1346 ,(2015) , 10.1001/JAMA.2015.2323
Patrick T O'Gara, Frederick G Kushner, Deborah D Ascheim, Donald E Casey Jr, Mina K Chung, James A de Lemos, Steven M Ettinger, James C Fang, Francis M Fesmire, Barry A Franklin, Christopher B Granger, Harlan M Krumholz, Jane A Linderbaum, David A Morrow, L Kristin Newby, Joseph P Ornato, Narith Ou, Martha J Radford, Jacqueline E Tamis-Holland, Carl L Tommaso, Cynthia M Tracy, Y Joseph Woo, David X Zhao, None, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Journal of the American College of Cardiology. ,vol. 61, pp. 485- 510 ,(2013) , 10.1016/J.JACC.2012.11.018
Derek P. Chew, Deepak L. Bhatt, A. Michael Lincoff, David J. Moliterno, Sorin J. Brener, Katherine E. Wolski, Eric J. Topol, Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials Circulation. ,vol. 103, pp. 961- 966 ,(2001) , 10.1161/01.CIR.103.7.961
Sorin J. Brener, David J. Moliterno, A. Michael Lincoff, Steven R. Steinhubl, Kathy E. Wolski, Eric J. Topol, Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications Analysis of 4 Recent Randomized Clinical Trials of Percutaneous Coronary Intervention Circulation. ,vol. 110, pp. 994- 998 ,(2004) , 10.1161/01.CIR.0000139868.53594.24
Adeel Shahzad, Ian Kemp, Christine Mars, Keith Wilson, Claire Roome, Rob Cooper, Mohammed Andron, Clare Appleby, Mike Fisher, Aleem Khand, Babu Kunadian, Joseph D Mills, John L Morris, William L Morrison, Shahzad Munir, Nick D Palmer, Raphael A Perry, David R Ramsdale, Periaswamy Velavan, Rod H Stables, Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial The Lancet. ,vol. 384, pp. 1849- 1858 ,(2014) , 10.1016/S0140-6736(14)60924-7